The Rosen Law Firm has initiated securities litigation against Picard Medical, Inc. (PMI), alleging that company defendants made materially false statements and concealed significant adverse business information from investors. The complaint specifically contends that defendants orchestrated a fraudulent stock promotion scheme utilizing social media misinformation and coordinated equity liquidation tactics, resulting in investor losses.
Investors who purchased or acquired Picard Medical securities are advised to take action before the April 13, 2026 deadline to petition the court for appointment as lead plaintiff in the class action proceeding. Selection as lead plaintiff carries significant responsibilities, including working with counsel to direct litigation strategy and decisions. The deadline represents a critical juncture for affected shareholders seeking to participate in potential recovery efforts.
This action is among multiple securities class actions recently filed by the firm, including cases against BlackRock TCP Capital Corp. (TCPC) and Beyond Meat, Inc. (BYND), each involving allegations of material misstatements or omissions regarding company operations and financial conditions.